Cary, NC, United States of America

Ved Srivastava

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Aktis Oncology, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ved Srivastava. Retrieved from https://idiyas.com/inventor/ved-srivastava-vo0t7lns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ved Srivastava

Introduction

Ved Srivastava is an accomplished inventor based in Cary, North Carolina. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for diagnosing and treating diseases.

Latest Patents

Ved Srivastava holds a patent for "Nectin-4 binding miniproteins, conjugates and uses thereof." This patent includes polypeptides and conjugates, such as radionuclide conjugates, which are useful in compositions and methods for treating, diagnosing, monitoring, and imaging diseases associated with the expression of Nectin-4.

Career Highlights

Ved is currently employed at Aktis Oncology, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients.

Collaborations

Some of his notable coworkers include William C Blackwell, III and Michael Lawrence Doligalski. Their collaboration enhances the innovative environment at Aktis Oncology, Inc.

Conclusion

Ved Srivastava's contributions to biotechnology and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…